DIABETIC RETINOPATHY

This study is testing if a daily anti-inflammatory eye drop (ketorolac) can slow the progression of diabetic retinopathy, a leading cause of blindness. Researchers will measure inflammatory markers in the eye and see if the eye drop reduces them and slows the disease. The study i…

This study is testing whether a daily cholesterol-lowering pill called fenofibrate can slow down or prevent eye damage in adults with Type 1 diabetes. It involves about 450 participants who already have early signs of diabetic eye disease. The goal is to see if taking the pill fo…

This study is testing a coaching program designed to help urban health clinics better use remote eye screening technology for their diabetic patients. The goal is to increase the number of patients who get their annual diabetic eye exam, which is crucial for catching vision-threa…

This study is testing a one-time gene therapy injection (called 4D-150) for adults with diabetic macular edema, a condition that causes swelling and vision loss. The goal is to see if this single treatment can safely reduce the need for the frequent eye injections patients curren…

This early-stage study is checking if it's safe and possible to treat vision loss by injecting a patient's own bone marrow stem cells directly into the eye. It involves 15 adults who have lost vision from conditions like macular degeneration or diabetic retinopathy. The main goal…

This study is testing a small, refillable implant placed in the eye to slowly release a medicine (ranibizumab) over time. It aims to see if this device is better than standard injections at improving diabetic retinopathy and preventing serious vision complications. The trial invo…

This study is testing whether artificial intelligence (AI) software can help eye doctors diagnose diseases from retinal photographs. Ten eye doctors and residents will review the same set of eye scan images, first without and then with the AI's help. Researchers will measure if u…

This 5-year study offers free vision screenings to New York City residents over 40 living in affordable housing. The goal is to detect eye diseases like glaucoma, cataracts, and diabetic retinopathy earlier in underserved communities. Researchers will track participants' vision o…

This study is testing a new type of eye scan called OCT angiography (OCTA) to see if it can better detect and measure damage from diabetic retinopathy. The goal is to provide doctors with clearer, more objective pictures of blood flow in the eye without needing dye injections. Re…

This study is testing a new type of eye scan to detect early blood vessel damage from diabetes, which can lead to blindness. The goal is to see if this scan, which doesn't require an injection, can work as well as the current standard test that does. Researchers are comparing sca…

This study aims to create a database of normal eye scans from healthy children. Researchers will then compare these normal scans to scans from children who have type 1 diabetes. The goal is to better understand how diabetes might affect the eyes over time, using a quick, non-inva…

This study aims to understand why some people with diabetes develop serious heart and kidney problems while others do not. Researchers are collecting detailed health information and blood samples from 48,000 people with diabetes in Hong Kong to look for genetic and other biologic…

This study aims to understand why diabetes damages the eyes. Researchers are comparing special blood cells from diabetic patients and healthy people to see if the cells' function can predict the development of diabetic retinopathy, a serious eye disease. The goal is to gather kno…

This study aims to better understand how poor blood flow in the eye contributes to vision loss in people with diabetes. Researchers will observe 60 people with a specific type of diabetic eye damage over two years, using advanced eye scans to measure blood flow. The goal is to fi…